Article
Variants in ACE2; potential influences on virus infection and COVID-19 severity.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Jun 2021
Bakhshandeh Behnaz, Sorboni Shokufeh Ghasemian, Javanmard Amir-Reza, Mottaghi Seyed Saeed, Mehrabi Mohammad-Reza, Sorouri Farzaneh, Abbasi Ardeshir, Jahanafrooz Zohreh
Abstract excerpt
The third pandemic of coronavirus infection, called COVID-19 disease, was first detected in November 2019th. Various determinants of disease progression such as age, sex, virus mutations, comorbidity, lifestyle, host immune response, and genetic background variation have caused clinical variability of COVID-19. The causative agent of COVID-19 is an enveloped coronavirus named severe acute respiratory syndrome...
Topics
- Angiotensin-Converting Enzyme 2
- COVID-19
- Cytokine Release Syndrome
- Disease Management
- Disease Susceptibility
- Genetic Variation
- Host-Pathogen Interactions
- Humans
- Immune Evasion
